These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 26255866)
41. Vaccination approaches for the prevention of urinary tract infection. Moriel DG; Schembri MA Curr Pharm Biotechnol; 2013; 14(11):967-74. PubMed ID: 24372245 [TBL] [Abstract][Full Text] [Related]
42. Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Olson PD; Hunstad DA Pathogens; 2016 Jan; 5(1):. PubMed ID: 26742078 [TBL] [Abstract][Full Text] [Related]
43. The nature of immune responses to urinary tract infections. Abraham SN; Miao Y Nat Rev Immunol; 2015 Oct; 15(10):655-63. PubMed ID: 26388331 [TBL] [Abstract][Full Text] [Related]
44. Urinary tract infection of mice to model human disease: Practicalities, implications and limitations. Carey AJ; Tan CK; Ipe DS; Sullivan MJ; Cripps AW; Schembri MA; Ulett GC Crit Rev Microbiol; 2016 Sep; 42(5):780-99. PubMed ID: 26006172 [TBL] [Abstract][Full Text] [Related]
45. Invasion of Host Cells and Tissues by Uropathogenic Bacteria. Lewis AJ; Richards AC; Mulvey MA Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28087946 [TBL] [Abstract][Full Text] [Related]
46. Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Subashchandrabose S; Mobley HL Metallomics; 2015 Jun; 7(6):935-42. PubMed ID: 25677827 [TBL] [Abstract][Full Text] [Related]
47. Urinary tract infections in children: microbial virulence versus host susceptibility. Svanborg C Adv Exp Med Biol; 2013; 764():205-10. PubMed ID: 23654069 [TBL] [Abstract][Full Text] [Related]
48. Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice. Zychlinsky Scharff A; Albert ML; Ingersoll MA J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286380 [TBL] [Abstract][Full Text] [Related]
49. Kicking Out Pathogens in Exosomes. Sergeeva OA; van der Goot FG Cell; 2015 Jun; 161(6):1241-2. PubMed ID: 26046431 [TBL] [Abstract][Full Text] [Related]
50. Infection: Uropathogenic Escherichia coli get a return TRP. Thoma C Nat Rev Urol; 2015 Jul; 12(7):362. PubMed ID: 26077998 [No Abstract] [Full Text] [Related]
51. Pathogenesis of urinary tract infection. Role of host defenses. Sobel JD Infect Dis Clin North Am; 1997 Sep; 11(3):531-49. PubMed ID: 9378922 [TBL] [Abstract][Full Text] [Related]
52. Using Proteomics to Identify Inflammation During Urinary Tract Infection. Yu Y; Pieper R Methods Mol Biol; 2019; 2021():259-272. PubMed ID: 31309511 [TBL] [Abstract][Full Text] [Related]
53. Susceptibility to Urinary Tract Infection: Benefits and Hazards of the Antibacterial Host Response. Ambite I; Nagy K; Godaly G; Puthia M; Wullt B; Svanborg C Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337480 [TBL] [Abstract][Full Text] [Related]
54. Fifteen-minute consultation: Why and how do children get urinary tract infections? Tullus K Arch Dis Child Educ Pract Ed; 2019 Oct; 104(5):244-247. PubMed ID: 30617151 [TBL] [Abstract][Full Text] [Related]
55. PITing it forward: A new link in the journey of uropathogenic E. coli in the urothelium. Joshi CS; Cegelski L; Mysorekar IU Cell Rep; 2022 Apr; 39(4):110758. PubMed ID: 35476986 [TBL] [Abstract][Full Text] [Related]
56. Urinary tract infection: immunological aspects. Girão MJ; Baracat EC; Lima GR Int Urogynecol J Pelvic Floor Dysfunct; 2002; 13(3):195-7. PubMed ID: 12140717 [TBL] [Abstract][Full Text] [Related]
57. Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields. Martin-Sanchez D; Fontecha-Barriuso M; Sanchez-Niño MD; Ramos AM; Cabello R; Gonzalez-Enguita C; Linkermann A; Sanz AB; Ortiz A Cell Death Dis; 2018 Jan; 9(2):118. PubMed ID: 29371637 [TBL] [Abstract][Full Text] [Related]
58. Host defense mechanisms in urinary tract infections. Neal DE Urol Clin North Am; 1999 Nov; 26(4):677-86, vii. PubMed ID: 10584610 [TBL] [Abstract][Full Text] [Related]